130 related articles for article (PubMed ID: 25876491)
21. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
Zheng XH; Lu LX; Li XZ; Jia WH
Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
[TBL] [Abstract][Full Text] [Related]
22. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.
Liu Z; Ji MF; Huang QH; Fang F; Liu Q; Jia WH; Guo X; Xie SH; Chen F; Liu Y; Mo HY; Liu WL; Yu YL; Cheng WM; Yang YY; Wu BH; Wei KR; Ling W; Lin X; Lin EH; Ye W; Hong MH; Zeng YX; Cao SM
Am J Epidemiol; 2013 Feb; 177(3):242-50. PubMed ID: 23255783
[TBL] [Abstract][Full Text] [Related]
23. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
[TBL] [Abstract][Full Text] [Related]
24. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China.
Zeng Y; Zhong JM; Li LY; Wang PZ; Tang H; Ma YR; Zhu JS; Pan WJ; Liu YX; Wei ZN
Intervirology; 1983; 20(4):190-4. PubMed ID: 6317603
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.
Chen H; Chen S; Lu J; Wang X; Li J; Li L; Fu J; Scheper T; Meyer W; Peng YH; Liu W
Cancer Prev Res (Phila); 2017 Sep; 10(9):542-550. PubMed ID: 28754665
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
27. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
29. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
30. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of incidence of nasopharyngeal carcinoma in populations with different fluctuation modes of immunoglobulin A antibody levels against Epstein-Barr virus capsid antigen].
Chen F; Liu K; Huang QH; Liu ZW; Cao SM
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Feb; 46(2):125-8. PubMed ID: 22490193
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
Ng MH; Chan KH; Ng SP; Zong YS
Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
34. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
35. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.
Jiang SQ; Liu Q
Ai Zheng; 2009 Feb; 28(2):177-80. PubMed ID: 19550133
[TBL] [Abstract][Full Text] [Related]
36. [Early NPC detection through serologic risk stratification and clinical follow-up of high risk subjects].
Shen Y; Ji M; Su N; Cheng W; Yu Y; Wu W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 25(6):274-6. PubMed ID: 21650063
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of nasopharyngeal carcinoma risk by EB virus antibody profile].
Cheng W; Chen G; Chen H; Luo R; Wu Z; Lu Y; Zheng B; Ji M; Liang J; Cen X; Wang D; Zong Y; Wu W
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):561-3. PubMed ID: 12667325
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic significance of serum anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma].
Cai YL; Li J; Lu AY; Zhong WM; Zheng YM; Gao JQ; Zeng H; Chen WS; Liang W; Tang MZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):119-22. PubMed ID: 24044217
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
[TBL] [Abstract][Full Text] [Related]
40. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]